CIDRAP newsletters options
Uganda's health ministry today reported 14 more lab-confirmed Ebola cases, pushing the outbreak total to 109. Health officials also reported 2 more deaths, raising the total to 30. Earlier in the outbreak before the first cases were confirmed, the ministry reported 20 suspected cases, all of them fatal.
An analysis of patients in a California health system found relatively high rates of flu-associated prescribing of select antibiotics in certain age-groups, researchers reported today in Epidemiology & Infection.
Compared with both uninfected people and COVID-19 outpatients, hospitalized COVID-19 patients were at dramatically higher risk for death, a blood clot in a vein, heart failure, and stroke within 30 days, suggests an observational study published yesterday in Heart.
Despite limited data, new WHO report highlights 19 fungi that represent the greatest threat to public health.
"If we really want to put COVID behind us, we have to keep the fight together," President Biden says.
Age-adjusted US COVID-19 death rates in 2020 were 30% higher in large, central metropolitan areas than in medium-sized cities, finds a new Centers for Disease Control and Prevention (CDC) analysis.
The United States is seeing unseasonably high levels of respiratory syncytial virus (RSV) cases among children, causing overflowing admissions at pediatric hospitals in several parts of the country.
"What's needed are vaccines that are durable, with a wide breadth of protection."
The CDC says BQ.1 and BQ.1.1 are spreading fairly quickly but still make up only a small proportion of all variants.
Diagnostic stewardship focuses not on antibiotics but on reducing urine cultures.
Lab-confirmed cases rise to 90, including 9 more in Kampala, the country's capital and largest city.
Late last week, the Centers for Disease Control and Prevention (CDC) reported a further rise in US flu activity, particularly in the southeast and south central regions, along with another variant H3N2 (H3N2v) flu case, this time in a Michigan resident who had indirect exposure to swine at an agricultural fair.
A study published late last week in JAMA Network Open links systemic symptoms—those that affect the entire body—after receipt of two doses of mRNA COVID-19 vaccine with stronger SARS-CoV-2 antibody responses than in vaccinees with no or localized symptoms.
Vaccine receipt proportions more than doubled in Black people and increased almost 50% in Hispanic groups.
Study adds further evidence that the antiparasitic drug is ineffective as a COVID-19 treatment.
A 5-year-old girl in northern Vietnam tested positive for H5 and is seriously ill.
A secondary analysis of results from a phase 3 trial shows that an investigative microbiome therapeutic reduced rates of recurrent Clostridioides difficile infection (rCDI) through 24 weeks and was well-tolerated, researchers reported this week in JAMA.
A third of US active-duty military service members who tested positive for COVID-19 reported new-onset or more difficulty with exercise and daily activities 1 month after diagnosis, but these symptoms diminished to pre-infection levels after 6 to 9 months, according to research presented at this week's Infectious Diseases Society of America (IDSA) ID Week in Washington, DC.
The vaccine in kids 6 months to 5 years triggered similar immune response and protection as in young adults.
Initial reports indicate the most recent cases were not among known contacts.
